These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Dissecting the expression landscape of cytochromes P450 in hepatocellular carcinoma: towards novel molecular biomarkers. Brodeur CM; Thibault P; Durand M; Perreault JP; Bisaillon M Genes Cancer; 2019 May; 10(3-4):97-108. PubMed ID: 31258835 [TBL] [Abstract][Full Text] [Related]
64. Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia. Van Acker HH; Versteven M; Lichtenegger FS; Roex G; Campillo-Davo D; Lion E; Subklewe M; Van Tendeloo VF; Berneman ZN; Anguille S J Clin Med; 2019 Apr; 8(5):. PubMed ID: 31035598 [TBL] [Abstract][Full Text] [Related]
65. The Immune Checkpoint Kick Start: Optimization of Neoadjuvant Combination Therapy Using Game Theory. West J; Robertson-Tessi M; Luddy K; Park DS; Williamson DFK; Harmon C; Khong HT; Brown J; Anderson ARA JCO Clin Cancer Inform; 2019 Feb; 3():1-12. PubMed ID: 30742484 [TBL] [Abstract][Full Text] [Related]
66. Single-nucleotide polymorphisms and mRNA expression of Abdul Aziz AA; Md Salleh MS; Mohamad I; Krishna Bhavaraju VM; Mazuwin Yahya M; Zakaria AD; Hua Gan S; Ankathil R J Genet; 2018 Dec; 97(5):1185-1194. PubMed ID: 30555068 [TBL] [Abstract][Full Text] [Related]
67. Antigen-specific active immunotherapy for ovarian cancer. Paijens ST; Leffers N; Daemen T; Helfrich W; Boezen HM; Cohlen BJ; Melief CJ; de Bruyn M; Nijman HW Cochrane Database Syst Rev; 2018 Sep; 9(9):CD007287. PubMed ID: 30199097 [TBL] [Abstract][Full Text] [Related]
68. MAGE-specific T cells detected directly ex-vivo correlate with complete remission in metastatic breast cancer patients after sequential immune-endocrine therapy. Janosky M; Sabado RL; Cruz C; Vengco I; Hasan F; Winer A; Moy L; Adams S J Immunother Cancer; 2014 Sep; 2(1):32. PubMed ID: 28837000 [TBL] [Abstract][Full Text] [Related]
69. Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia. Anguille S; Van de Velde AL; Smits EL; Van Tendeloo VF; Juliusson G; Cools N; Nijs G; Stein B; Lion E; Van Driessche A; Vandenbosch I; Verlinden A; Gadisseur AP; Schroyens WA; Muylle L; Vermeulen K; Maes MB; Deiteren K; Malfait R; Gostick E; Lammens M; Couttenye MM; Jorens P; Goossens H; Price DA; Ladell K; Oka Y; Fujiki F; Oji Y; Sugiyama H; Berneman ZN Blood; 2017 Oct; 130(15):1713-1721. PubMed ID: 28830889 [TBL] [Abstract][Full Text] [Related]
70. CYP1B1 Activates Wnt/β-Catenin Signaling through Suppression of Herc5-Mediated ISGylation for Protein Degradation on β-Catenin in HeLa Cells. Park YS; Kwon YJ; Chun YJ Toxicol Res; 2017 Jul; 33(3):211-218. PubMed ID: 28744352 [TBL] [Abstract][Full Text] [Related]
71. Immunotherapy in head and neck cancer: aiming at EXTREME precision. Szturz P; Vermorken JB BMC Med; 2017 Jun; 15(1):110. PubMed ID: 28571578 [TBL] [Abstract][Full Text] [Related]
72. Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer. Swan R; Alnabulsi A; Cash B; Alnabulsi A; Murray GI Oncotarget; 2016 Jul; 7(29):46509-46527. PubMed ID: 27341022 [TBL] [Abstract][Full Text] [Related]
73. The serotonin transporter promotes a pathological estrogen metabolic pathway in pulmonary hypertension via cytochrome P450 1B1. Johansen AK; Dean A; Morecroft I; Hood K; Nilsen M; Loughlin L; Anagnostopoulou A; Touyz RM; White K; MacLean MR Pulm Circ; 2016 Mar; 6(1):82-92. PubMed ID: 27162617 [TBL] [Abstract][Full Text] [Related]
74. Expression Profile of Genes Related to Drug Metabolism in Human Brain Tumors. Stavrinou P; Mavrogiorgou MC; Polyzoidis K; Kreft-Kerekes V; Timmer M; Marselos M; Pappas P PLoS One; 2015; 10(11):e0143285. PubMed ID: 26580399 [TBL] [Abstract][Full Text] [Related]
75. Whole Tumor Antigen Vaccines: Where Are We? Chiang CL; Coukos G; Kandalaft LE Vaccines (Basel); 2015 Apr; 3(2):344-72. PubMed ID: 26343191 [TBL] [Abstract][Full Text] [Related]
76. Current status of gene therapy for breast cancer: progress and challenges. McCrudden CM; McCarthy HO Appl Clin Genet; 2014; 7():209-20. PubMed ID: 25419154 [TBL] [Abstract][Full Text] [Related]
77. Pilot study of intratumoral injection of recombinant heat shock protein 70 in the treatment of malignant brain tumors in children. Shevtsov MA; Kim AV; Samochernych KA; Romanova IV; Margulis BA; Guzhova IV; Yakovenko IV; Ischenko AM; Khachatryan WA Onco Targets Ther; 2014; 7():1071-81. PubMed ID: 24971017 [TBL] [Abstract][Full Text] [Related]
78. Immune response to sipuleucel-T in prostate cancer. Thara E; Dorff TB; Averia-Suboc M; Luther M; Reed ME; Pinski JK; Quinn DI Cancers (Basel); 2012 Apr; 4(2):420-41. PubMed ID: 24213318 [TBL] [Abstract][Full Text] [Related]
79. Immunocytokines: a review of molecules in clinical development for cancer therapy. List T; Neri D Clin Pharmacol; 2013; 5(Suppl 1):29-45. PubMed ID: 23990735 [TBL] [Abstract][Full Text] [Related]